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Abstract
Parkinson’s disease (PD) is an incurable age-related neurodegenerative disorder affecting both the central and peripheral
nervous systems. Although common, the etiology of PD remains poorly understood. Genetic studies infer that the disease
results from a complex interaction between genetics and environment and there is growing evidence that PD may
represent a constellation of diseases with overlapping yet distinct underlying mechanisms. Novel clinical approaches will
require a better understanding of the mechanisms at work within an individual as well as methods to identify the specific
array of mechanisms that have contributed to the disease. Induced pluripotent stem cell (iPSC) strategies provide an
opportunity to directly study the affected neuronal subtypes in a given patient. Here we report the generation of iPSC-
derived midbrain dopaminergic neurons from a patient with a triplication in the a-synuclein gene (SNCA). We observed that
the iPSCs readily differentiated into functional neurons. Importantly, the PD-affected line exhibited disease-related
phenotypes in culture: accumulation of a-synuclein, inherent overexpression of markers of oxidative stress, and sensitivity
to peroxide induced oxidative stress. These findings show that the dominantly-acting PD mutation is intrinsically capable of
perturbing normal cell function in culture and confirm that these features reflect, at least in part, a cell autonomous disease
process that is independent of exposure to the entire complexity of the diseased brain.
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Introduction
Parkinson’s Disease (PD) is a debilitating neurodegenerative
disorder characterized by the loss of neurons in both the
peripheral and central nervous system [1,2,3,4,5,6]. The majority
of cases result from unknown etiology causing widespread neuron
loss in the midbrain, cerebral cortex, olfactory bulb, and
peripheral nervous system. Neuron degeneration is pronounced
in the dopaminergic neurons of the substantia nigra pars compacta
leading to the diagnostic clinical features of bradykinesia, rigidity
and tremor [1,2,3,4,5,6,7].
Genetic studies have implicated several potential mechanisms
but the etiology of Parkinson’s disease remains obscure. In a large
cohort of patients, Lewy bodies and Lewy neurites form in CNS
and autonomic peripheral nervous system (PNS) neurons. These
large intracellular proteinaceous inclusions are rich in a-synuclein
and ubiquitin, an observation that suggests a role for a-synuclein
and the proteasome in the molecular development of sporadic and
genetic PD [8]. However, not all patients with PD develop Lewy
bodies. Although alterations in LRRK2 are commonly associated
with PD, many of these patients do not exhibit a Lewy phenotype
and it is thought that protein aggregration may be a disease
modifier [9]. Methods to identify patients with an intrinsic
aggregration phenotype may be useful in categorizing disease as
well as in correctly targeting disease-modifying interventions to an
appropriate class of patients. To explore the potential use of iPSC-
derived neurons in detecting protein accumulation and aggrega-
tion phenotypes, we report the generation of iPSCs from a patient
with a dominant autosomal form of PD caused by triplication of
the SNCA locus. Dosage is known to influence disease progression
with triplications causing earlier onset and more rapid progression
than duplications of SNCA [10,11,12,13]. Given their pronounced
in vivo phenotype, SNCA triplications were selected to provide the
highest probability of detecting disease-related phenotype that
may be useful in categorizing disease characteristics in patient-
derived neurons.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e26159Familial autosomal dominant forms of PD have been docu-
mented in families with SNCA mutations or gene duplication/
triplications as well as in families with mutations in proteins
regulating the ubiquitin-proteasome pathway [11,14,15]. a-
Synuclein protein aggregation and markers of cellular stress are
also seen in other neurodegenerative disorders including dementia
with Lewy bodies, pure autonomic failure, and multiple system
atrophy [16]. Although overexpression of a-synuclein transgenes
leads to protein aggregation in normal cells, the study of native
processes leading to aggregation in affected individuals has been
hindered by the inaccessibility of human neurons in vivo, the
limitations inherent in studying postmortem samples from PD
patients, and the inability to accurately recapitulate human disease
in transgene models [12,17]. Here we report that neurons derived
from a SNCA triplication patient exhibit intrinsic protein
accumulation and aggregation phenotypes.
Results
Patient Clinical Presentation
The subject of this study was a 48-year-old male with an SNCA
triplication (Trpl-HDF). The patient presented with early onset,
autosomal dominant, PD at age 38. The patient was left-handed
and had been in excellent health most of his life. His initial
symptoms in 2007 were fatigue, tremor and decreased dexterity.
At that time, he was not experiencing any changes in speech, gait
or cognition. He had undergone an MRI scan, which was
unremarkable. He exhibited a resting and mild intention tremor,
but his gait was normal. Thus, in 2007, the patient appeared to
have mild Parkinson’s disease and no medication was required.
At the time of the clinical examination in summer 2008, the
patient noted mild problems with recent memory. He did not
experience any psychiatric symptoms such as delusions or
hallucinations but reported some anxiety and slight depression.
He also reported urinary urgency and occasional constipation. He
indicated that he had normal sleep patterns but in speaking with
his wife he did exhibit nocturnal features suggesting REM
behavioral disorder. He had undergone a sleep study and
apparently obstructive sleep apnea was suspected, but did not
tolerate continuous positive airway pressure. The patient stated
that his sense of smell was poor for at least one year and the B-SIT
smell test showed abnormal sense of smell with 6/12 points. From
time to time he noted periodic blurring of vision and diplopia and
had obtained new corrective lenses. He was also experiencing
motor fluctuations on his current medication schedule. He stated
that in the ‘‘on’’ state he is nearly normal, but continued to
experience difficulty with his handwriting. When he is in the ‘‘off’’
state or when the medication wears out, his speech slowed, he
drooled, his handwriting worsened, and he had more difficulty
with dexterity such as dressing or hygienic activities. He had not
noticed any difficulty with his balance, but reported that when his
medication wore off he experienced hesitation on turning. Tremor
also worsened when the medication wore off. In addition, the
patient noted some upper back pain. He estimated about 80% of
the day was in the ‘‘on’’ state and had not experienced any
dyskinesia. There was a mild to moderate rest tremor of his left
hand and a slight tremor of his right hand in addition to an action
tremor of mild degree left greater than right. He was able to rise
from the chair and walk with no difficulty. His stride was normal
but there was axial rigidity and loss of arm swing bilaterally. A
slight hesitation on turning when asked to multitask while he
walked. There was no sign of ataxia on finger nose or heel shin
testing and he did not exhibit dystonia or dyskinesia. Symptoms
suggested typical progression of Parkinson’s disease.
Generation of iPSCs
A skin biopsy was taken and iPSCs were generated from
primary human dermal fibroblasts (Trpl-HDF) and from HDFs
isolated from his unaffected sister (Ctrl-HDF) with a normal SNCA
copy number. Trpl-HDF and Ctrl-HDF were reprogrammed by
induced expression of the exogenous transcription factors OCT4,
SOX2, KLF4, and c-MYC, through retroviral gene insertion
[18,19,20,21,22], and resulting iPSC clones were expanded and
characterized for human embryonic stem cell (hESC)-like
properties (Fig. 1A). Multiple iPSC clones from each donor line
were similar to hESCs with respect to morphology, expansion,
gene expression, epigenetic regulation, and teratoma formation.
Representative hESC-like clones from each donor were selected
for further analysis. All clones that were analyzed maintained
hESC-like properties in culture for more than 30 passages on MEF
feeders and in feeder free media and expressed pluripotency-
associated antigens: alkaline phosphatase (AP), TRA1-60, TRA1-
81, NANOG, SSEA-1, SSEA-3, and SSEA-4 (Fig. 1B and Fig.
S1A). To ensure line stability, selected reprogrammed clones were
further examined for karyotype and silencing of exogenous
reprogramming factors. We observed that the karyotype was
normal and that there was robust silencing of the exogenous
retroviral-based reprogramming factors, as detected by RT-PCR,
while expression of endogenous pluripotency transcription factors
was comparable to levels in native H9 hESCs (Fig. S1B and C).
Other characteristics of the iPSCs also matched those of hESCs.
The NANOG and OCT4 promoters were hypermethylated in the
untransduced donor fibroblasts and hypomethylated in the
reprogrammed iPSCs and H9 hESCs (Fig. S2A). Imprinted genes
maintained their differentially-methylated state in reprogrammed
colonies, confirming iPSC epigenetic stability and suggesting
reduced tumorigenic risk and complete reprogramming (Fig. S2B)
[23,24,25]. Likewise, iPSC telomerase activity was comparable to
hESCs and was significantly elevated compared to untransduced
fibroblasts (Fig. S3) [26,27]. Finally, when we tested the ability of
iPSC lines to form cell types indicative of all three germ layers
(mesoderm, ectoderm, and endoderm), we observed that the lines
spontaneously differentiated into characteristic cells from each
germ layer both in vitro and in vivo in teratoma assays (Figs. 1C and
Fig. S4A and B).
Neuronal differentiation
To generate neurons, independently derived iPSC clones from
the SNCA triplication patient (Trpl8, Trpl17 and Trpl43), the
unaffected sibling (Ctrl1, Ctrl2 and Ctrl3) and hESCs (H9) were
differentiated according to the method of Perrier and colleagues
[28]. hESC-like colonies were mechanically isolated and sequen-
tially exposed to recombinant proteins and growth factors known
to be involved in the patterning of dopaminergic neurons in vivo
(Fig. S5). Independent of cell line, differentiation in vitro followed a
developmental sequence with cells first forming neural rosettes, or
rings of neuroectodermal progenitors, which subsequently gener-
ated neurons. Neural rosettes were present from approximately
day 9 of neural induction until passaging at day 28 (Fig. 2A). The
neural progenitors were then passaged onto laminin-coated
coverslips and patterned with SHH (Sonic Hedgehog) and FGF8
(Fibroblast Growth Factor 8) prior to terminal differentiation in
the presence of TGF-b3 (transforming growth factor b-3) (Fig. S5).
Immunofluorescent (IF) staining was used to evaluate differen-
tiated cultures for the presence of nestin, a type VI intermediate
filament protein indicative of neural progenitor cells; doublecortin
(DCX), a microtubule-associated protein found in immature
neurons; and tyrosine hydroxylase (TH), the rate-limiting enzyme
in dopamine biosynthesis, indicative of dopaminergic neurons.
iPSC-derived DA Neuron Phenotype Characterization
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positive neural progenitors, DCX-positive immature neurons and
TH-positive mature DA neurons (Fig. 2B).
Neurons were often localized in islands of differentiating nestin-
positive progenitor cells. These dense aggregates produced
extensive axonal outgrowth (Fig. S6A) and TH-positive neurons
were found within and around these differentiating clusters (Fig.
S6A, B). Cells within the differentiating clusters were PAX6
positive, confirming their neuroectodermal origins (Fig. S6C).
Cells were also positive for LMX1a (Fig. 2F) and FOXA2, markers
that are expressed by floor plate progenitors and floor plate-
derived midbrain dopaminergic neurons (Fig. 2G) [29,30]. TH-
immunoreactive neurons also expressed engrailed-1 (EN1),
pituitary homeobox 3 (pitx3) and the midbrain associated ion
channel G protein-activated inward rectifier potassium channel 2
(GIRK2) (Fig. 2C–E and Fig. S7).
Scoring of the relative abundance of TH-positive neurons
indicated that there were no significant differences between iPSC
or hESC lines (Fig. 2H). Combined, the markers confirm midbrain
dopaminergic neuron development and indicate that the under-
lying genetic anomaly in the PD iPSC did not significantly impact
the formation of these neurons in culture.
To further characterize the progression of events that
accompanies differentiation, gene expression profiles were evalu-
ated at different stages during the differentiation process using
microfluidic, high-density quantitative PCR (qPCR). Samples of
500–1000 cells were manually collected from replicate cultures of
undifferentiated pluripotent cells, cultures highly enriched for
neural rosettes, and cultures enriched for mature neurons (days 0,
28 and 50, respectively). Cells were lysed and processed for
expression analysis of a 96-gene panel diagnostic of pluripotent
stem cells, endoderm, mesoderm, neural crest and CNS cells,
including neurons and glia (Material S1). Relative CT values for
expression were calculated as the difference between the gene of
interest and the geometric mean of four housekeeping genes:
GAPDH, CTNNB1, EEF1a1, and CENTB3 per sample.
We used cluster analysis to examine gene expression and time
points across the sample groups (Fig. 2J). We observed that
samples self-clustered primarily by stage of differentiation and
secondarily by iPSC line confirming that SNCA triplication and
control lines were highly similar in both gene expression and
differentiation patterns. Moreover, genes clustered into functional
groups that correlated with developmental and cell-type specific
groups, providing evidence of native differentiation cascades
expected for normal neural development. The clustered group of
undifferentiated samples from Trpl8, Trpl17, Trpl43 and Ctrl1,
Ctrl2 and Ctrl3 iPSCs, as well as, H9 hESCs showed higher
expression of the self-clustered group of pluripotency related
genes, FOXD3, NANOG, LIN28, OCT4, TERT and DNMT3B
relative to differentiated cultures (Fig. S8 and S9). A second
cluster, containing general neuroectodermal markers, was upre-
gulated in expression in samples that were enriched in rosettes and
differentiated DA neurons relative to undifferentiated samples (Fig.
S8). Finally, genes associated with fully developed DA neurons,
including SHH, BDNF, MAO-A and MAO-B, were enriched in
expression in samples of mature neurons, as compared to rosettes
and undifferentiated cells (Fig. S8). As a control, human fetal brain
mRNA samples were run in parallel during the qPCR assay and
clustered most significantly with the neural progenitors and
mature neurons present after 50 days of differentiation.
Elevated SNCA expression
SNCA triplication is associated with elevated expression and
accumulation of a-synuclein. We noted that some SNCA
triplication neurons displayed abnormally bright IF staining for
a-synuclein protein, however, these neurons did not co-express
TH (Fig. 3A and Fig. S9). Copy number analysis confirmed that
Trpl17 HDFs and iPSCs possessed four copies of SNCA, compared
to two copies of SNCA in H9 and Ctrl2 derived cells (Fig. 3B) and
qRT-PCR showed mRNA abundance in neuronal cultures was
1.44 times higher in Trpl17 compared to Ctrl2 cultures and 7.17
times higher than hESC H9 cultures (the latter being statistically
significant, p=0.013) (Fig. 3C). a-synuclein accumulation was
further quantified by Western analysis of protein lysates from
Trpl17, Ctrl2 and H9 60-day differentiated neuron cultures.
Although the western blot was unable to take into account
expression heterogeneity between the cells of each culture, 17 kD
monomeric a-synuclein was elevated approximately 2-fold in
Trpl17 cultures compared to sibling Ctrl2 or hESC H9 derived
neuronal cultures (Fig. 3D and E). These findings are consistent
with blood and post-mortem tissue samples from SNCA triplication
individuals, in which a-synuclein levels are higher relative to
controls [31].
Oxidative stress, protein aggregation-related genes and
cell death
To determine whether protein aggregation was accompanied by
an increase in cell stress, the transcription level of 14 oxidative
stress and protein aggregation-related genes (Material S1) was
analyzed in DA neural cultures. Within the 14-gene panel,
expression of DNAJA1, HMOX2, UCHL1, HSPB1 and MAO-A
was found to be significantly different across Trpl17, Ctrl2 and H9
cultures in a three way ANOVA. For each of these genes, a post-
hoc test showed 1.5- to 4-fold elevated expression in Trpl17 DA
neural cultures compared to controls (Fig. 4A–E). HMOX2 is a
known oxidative stress related protein, while DNAJA1 and
HSPB1, a heat shock related protein, have been recognized as
aggregate interacting proteins [32]. Mutations in UCHL1, a
ubiquitin chaperone that participates in the normal removal of
unwanted protein through the proteasomal pathway, can lead to
familial forms of PD [7], while MAO has been implicated in
hypothesized PD progression models by increasing the quantity of
reactive oxygen species [33]. Related to the UCHL1 expression
difference, a small number of ubiquitin positive cells were observed
in the SNCA triplication neuronal cultures (Fig. S10A). The ability
to isolate single midbrain dopaminergic neurons from these
cultures would enable more detailed and sensitive analysis of PD
associated phenotypes. However, the alterations in cell stress-
related gene expression analyzed at the aggregated culture level
and the presence of a-synuclein accumulation suggest that an
SNCA triplication induces or increase the susceptibility of cell-
Figure 1. Analysis of pluripotency of iPSC lines. (A) Human dermal fibroblasts (HDF) from Trpl17 and Ctrl2 were reprogrammed into iPSCs
capable of forming colonies on mouse embryonic fibroblasts (MEFs) that expressed pluripotency associated antigens, SSEA3, TRA1-60, TRA-181,
NANOG, and SSEA4 and were negative for lineage marker SSEA1. (B) Pluripotency of iPSC lines Trpl17 and Ctrl2 was assayed through
immunohistochemistry of in vivo teratoma formation, demonstrating formation of cell types from all three germ layers; epithelial tissue (endoderm),
cartilage (mesoderm) and neuronal tissue (ectoderm). Pluripotency potential was further characterized through embryoid body differentiation in
vitro. Immunofluorescent staining confirmed the presence of cell types indicative of all three germ layers, bIII-tubulin and TH (ectoderm), desmin and
a-SMA (mesoderm) and a-fetoprotein (endoderm; Figure S4A).
doi:10.1371/journal.pone.0026159.g001
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culture.
To determine whether cell death resulted from this increase in
cell stress, we stained differentiated neurons for cleaved caspase-3
protein, a key regulator in cell apoptosis. DA neurons showed no
significant differences in the abundance of caspase-3 positive cells
under baseline conditions. However, when the antioxidant
ascorbic acid was withdrawn from the culture media and cells
were challenged with 200 mM hydrogen peroxide for 24-hours,
significantly higher numbers of Caspase-3 positive TH neurons
were observed in Trpl17 and Trpl43 compared to controls
(Fig. 4F,G and Fig. S10B). Although this hydrogen peroxide screen
does not take into account single cell variability of alpha-synuclein,
it does demonstrate that cultures that accumulate alpha-synuclein
are more vulnerable to oxidative stress induced cell death.
Discussion
Parkinson’s disease results from a complex interplay of genetics
and environment. Not all patients exhibit identical features and
future clinical approaches may benefit from diagnostic methods
that predict disease mechanism and classify patients by virtue of
neuron-intrinsic disease features. Here, we present data that
indicates that differentiation of pluripotent stem cells may provide
a cell-based model to detect cell autonomous disease processes
based on protein deregulation/accumulation. The cell lines that
we generated were derived from a PD patient with a naturally-
occurring genomic triplication of the SNCA gene and his
unaffected sibling. Importantly, the PD-affected line exhibited
several disease-related phenotypes in culture: accumulation of a-
synuclein, inherent overexpression of markers of oxidative stress,
and sensitivity to peroxide induced oxidative stress. These findings
show that the dominantly-acting PD mutation is intrinsically
capable of perturbing normal cell function in culture and confirm
that these features reflect, at least in part, a cell autonomous
disease process that is independent of exposure to the entire
complexity of the diseased brain. Importantly, this cell line
contains wild type, non-mutant, a-synuclein, and thus is likely to
reflect key characteristics relevant to the pathogenesis of the
greater idiopathic PD patient population that display a similar
protein aggregations. In idiopathic disease a-synuclein levels may
be deregulated through epigenetics, environmental or a multifac-
torial process that result in similarly elevated a-synuclein and
thereby initiate and propagates PD in a similar manner to the
SNCA triplication neurons presented here.
Although the data presented here indicates that elevated wild-
type a-synuclein is sufficient for cell-intrinsic vulnerability, the
mechanism of pathogenic action is still unknown. The elevation of
oxidative stress and aggregation of interacting proteins in the
diseased line are consistent with free radical accumulation,
perhaps as a result of protein aggregation-induced alterations in
ubiquitin-proteasome function. Such perturbations in protein
dynamics may influence the efficient removal or neutralization
of oxidative molecules from the mitochondria’s electron transport
chain or tyrosine hydrolysis in dopaminergic neurons leading to
increased neuron vulnerability. Although loss of midbrain
dopaminergic neurons produces the prominent clinical features
of PD, the degenerative process extends well beyond the midbrain
dopaminergic neurons to affect autonomic function, cognition and
mood. We confirm here that both TH-positive and TH-negative
neurons display ubiquitinated intracellular inclusions. This is
consistent with the dominant disease inheritance of the wild-type
SNCA triplication with expression of SNCA in all neurons, and
indicates that patient-derived iPSC can be used to study disease
mechanisms and selective vulnerably across the many neuron
subtypes involved in PD.
SNCA is not the only gene linked to hereditary PD. Mutations
in LRRK2, UCHL1, PARKIN and others can lead to autosomal
dominant inherited forms of PD, suggesting that the proteins
encoded by these genes play an important role in neural cell
homeostasis. In parallel work, we have shown that vulnerability
and PD related phenotypes can be detected in iPSC-derived DA
neurons, however, the apoptotic vulnerability was lower in the
SNCA triplication lines than observed in DA neurons derived
from a LRRK2-G2019S homozygous iPSC line [34]. Although
both LRRK2 and SNCA mutations induce autosomal dominant
forms of PD, the SNCA triplication line expresses higher levels of a
normal protein while the LRRK2-G2019S missense mutation
encodes a mutant protein, which in the homozygous state
produces a more pronounced apoptotic vulnerability. In contrast,
intracellular inclusions appeared to be more pronounced in
differentiated neurons carrying the SNCA triplication.
Protein accumulation, oxidative stress marker increases and
caspase activity in SNCA triplication iPSC-derived DA neurons
demonstrates that PD linked mutations can produce detectable
features of disease in young neurons, and we anticipate that the
derivation of iPSC from both genetic and idiopathic patients will
ultimately define whether a given mutation or more complex
polygenic background confers a cell-autonomous vulnerability or
whether the disease process in a given class of patients requires
additional environmental or epigenetic contribution to confer
selective vulnerability in dopaminergic neurons. The ability to
observe disease-related phenotypes in PD iPSC-derived neurons
across patient groups provides a useful platform for studying
Figure 2. Characterization of directed dopaminergic neuron differentiation. (A) Trpl17 and Ctrl2 neural induction time course 56phase
contrast images at iso-location (except where noted): Days 3, 6, 9 in the upper row are images of the same location in each culture. However, rosettes
formed on the expanding colony periphery and not at the initial site of colony adhesion. Thus, the lower row shows days 9, 12, and 14 at a different
location in each culture. Formations of neural rosettes (example in white circle) were visible begging on day 9 and continued to expand and
proliferate through day 14 and beyond. (B) IF analysis of pluripotent lines H9, Trpl17, and Ctrl2 for DAPI, Nestin, DCX and TH. The presence of
significant numbers of TH positive neurons demonstrates the ability to differentiate and enrich for dopaminergic neurons. IF confocal micrograph
demonstrating (C) midbrain specific transcription factor pitx3 colocalization with TH and SNCA in Trpl17 dopaminergic neurons; (D) midbrain
associated ion channel GIRK2, (E) midbrain specific transcription factor EN1, and (F) midbrain associated transcription factor LMX1a were expressed in
Trpl17 and Ctrl2 dopaminergic neurons. (G) FOXA2, a marker expressed by floor plate progenitors and their midbrain dopaminergic neuron
derivatives, was expressed in Trpl17 and Ctrl2 dopaminergic neurons. (H) Single cell patch-clamp recordings demonstrate that neurons derived from
Trpl17 iPSCs are electrophysiologically functional with multiple spike trains and a normal 270 mV resting potential. (I) Clustering of samples and
genes in a 96696 microfluidic qPCR array. Samples clustered by differentiation stage (undifferentiated, rosette and DA neurons) rather than by line
(H9, Trpl8, Trpl17, Trpl43, Ctrl1, Ctrl2, or Ctrl3.). Fetal brain samples clustered with DA neurons rather than undifferentiated or rosettes cells. Five self-
clustered gene sections, of the full 96 genes (Figure S7), were examined closely, demonstrating self-assembly of pluripotency, general neural, and
mature neural related genes with expression patterns that correlate to sample developmental stage and human fetal brain samples. (J) The number
of TH positive cells per well was not significantly different, although Trpl17 had a greater variance. Scale bars=100 mm (a–b), 10 mm (c, e), 25 mm (d,
f–g) and error bars=S.E.M.
doi:10.1371/journal.pone.0026159.g002
iPSC-derived DA Neuron Phenotype Characterization
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impacts and potential therapeutic applications.
Materials and Methods
Primary cell derivation and culture
Potential patients with specific genetic disease and healthy
volunteers were informed of the project through poster advertising
and referrals through patient advocacy and disease focus
organizations (Parkinson’s Institute). Written informed consent
was obtained form all patients involved in the study. A Stanford
institutional review board approved the primary cell line
derivation (approval IRB-15028) and Stanford’s stem cell research
oversight committee (approval SCRO-212) approved all subse-
quent tissue use and experimentation. Potential donors were
screened for men and women between the ages of 18 and 75 that
Figure 3. Characterization of midbrain DA neurons and phenotypic differences between pluripotent lines. (A) IF confocal micrographs
of DAPI, a-synuclein, TH, and DCX, demonstrate variable a-synuclein accumulation in Trpl17 derived DA neurons. (B) SNCA gene copy number
computation through qPCR of SNCA 3rd intron. Absolute copy number (2622DCT) is reported: Ctrl-HDF, Ctrl2, and H9 ES cells all had a normal
diploid copy number. Trpl-HDF and Trpl17 possessed 4 allelic copies of SNCA, consistent with a single allele triplication. (C) SNCA mRNA expression
analysis shows an ANOVA significant difference between all three lines, and a post-hoc significant SNCA expression difference between Trpl17 and H9
neurons. (D) Western blots show greater abundance of 17 kDa monomeric a-synuclein in Trpl17 DA cultures than control Ctrl2 and H9. Cells from
two independently differentiated wells are shown per sample. (E) The ratio of monomeric a-synuclein/GAPDH was calculated for each sample and
results are expressed as the mean of two samples. Scale bar=50 mm. Error bars=SEM in c and d and sample range in g.* p ,0.05 and **p,0.001.
doi:10.1371/journal.pone.0026159.g003
iPSC-derived DA Neuron Phenotype Characterization
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consent was obtained, primary human dermal fibroblasts (HDF)
from the medial arm dermis of a 42-year-old male with SNCA
triplication and his 46-year-old unaffected sister were obtained by
first cleaning the region was cleaned with an alcohol swab and
injecting 2–3 ml of 1% lidocaine with 1:100,000 diluted
epinephrine. Then, a 4 mm dermal specimen was removed with
a core punch biopsy instrument and placed in sterile PBS, while
the skin defect was closed with a 4-0 nylon suture and covered with
a double antibiotic ointment bandage. Sutures were removed after
2 weeks. The skin tissue biopsy was washed in Ca
2+ and Mg
2+ free
Dulbecco PBS (Invitrogen, Carlsbad, CA) and minced into small
pieces before being seeded onto gelatin coated 6-well cell culture
flasks (Corning, Acton, MA) containing DMEM/F12 supplement-
ed with 100 IU/ml penicillin, 100 mg/ml streptomycin (Invitro-
gen), 10% FBS (DMEM/FBS culture media) and cultured at
37uC37C in 5% CO2. A minimal amount of culture media was
used to promote tissue attachment to the gelatin-coated surface
(1 ml of culture media per well). The media was brought up to
4 ml per well once the skin fragments attached and the media was
changed every 2 days. Once fibroblasts began to migrate out, the
attached biopsy fragments and any connected epithelial cells were
removed and the fibroblasts were cultured to 80–90% confluence.
This primary culture was passaged by brief exposure to 0.15%
trypsin-EDTA (Invitrogen, Grand Island, NY) and seeded into
four gelatin-coated 175 cm cell culture flasks with fresh DMEM-
F12/FBS culture media. These somatic cells were cultured until
they reached 90% confluence and subsequently frozen in
DMEM/FBS culture media supplemented with 10% dimethyyl
sulphoxide (DMSO, Sigma, St. Louis, MO) in aliquots of one
million cells per cryovial. These somatic cells were thawed as
required for reprogramming studies.
Mouse embryonic fibroblast preparation
Mouse embryonic fibroblasts (MEFs) were prepared by
sacrificing pregnant CF-1 mice (Charles River Laboratories),
transferring fetuses to fresh PBS and rinsing until blood is absent.
Animal work was approved under Stanford guidelines for animal
safety and received approval from Stanford’s administrative panel
on laboratory animal care (approval APLAC-16146) and SCRO
(approval SCRO-212) boards. Fetal heads and visceral organs
were mechanically removed and the remaining carcass was rinsed
in PBS, finishing in a rinse containing 5 ml Trypsin. Carcass tissue
was cut into small pieces using scalpels, transferred from individual
fetuses to a 15 ml centrifuge tube and incubated in 5% CO2 at
37uC37C for 20 min. 10 ml feeder medium was added to
neutralize the Trypsin and the solution was pipetted up and
down with a 25 ml stripper pipette. The sample was centrifuged at
1000 RPM for 5 min, the supernatant was aspirated and the
sample was resuspended in 10 ml fresh feeder medium – repeated
until solution was devoid of blood. Cells were plated at one fetus
per T175 gelatin coated flasks with 30 ml feeder medium and
incubated in 5% CO2 at 37uC.37C. Cells were subsequently
passaged every 2–6 days (when flasks neared 90% confluency) for
5–7 passages, irradiated with 3000 rad gamma waves and then
frozen down in DMSO.
Retroviral production and infection
293FT cells were cultured in T175 flasks to ,90% confluence
on the day of transfection. For each 293FT T175 flask, two
premixes were prepared; (1) 10 ug VSVG, 15 ug delta8.9, 10 ug
retroviral vectors carrying Oct3/4, Sox2, Klf4 and c-Myc in 10 ml
Opti-MEM; and (2) 120 ul Lipofectamine in 5 ml Opti-MEM.
The premix solutions were incubated for 5 min at room
temperature and then mixed gently by hand inversion. The
resulting mix was then allowed to sit for 20 min at room
temperature. The 293FT cells were treated with the resulting
15 ml mix and incubated in 5% CO2 at 37uC37C for 6 hours,
after which the transfection mixture as replaced with 18 ml of
10% FBS in DMEM+Glutamax and incubated in 5% CO2 at
37uC37C for 72 hours. Harvest the supernatant in 50 ml conical
tubes and spin down at 2000 rpm for 5 minutes. Filter the
supernatant through Millex-HV 0.45 filter unit and store briefly
for concentrating. To concentrate the virus, 30 ml fresh viral
supernatant was concentrated 1006 by centrifugation at
17,100 rpm for 2:20 hours at 20uC20C in a Beckman Coulter
Optima L-80XP Ultracentrifuge and re-suspended in 300 ul of
10% FBS/DMEM. 1006viral stock stored at 280uC80C. Target
fibroblasts were prepared at 1610
5 cells per well of a 6-well plate.
The four prepared viral supernatants were mixed to the
appropriate concentrations with fresh MEF medium and supple-
mented with 8 ng/mL polyprene and cultured with the cells
overnight. The next day, cells were washed once with medium and
incubated overnight with MEF medium to allow recovery from the
infection. The retroviral infection was repeated for a total of two
rounds.
Reverse transcription, pre-amplification and RT-PCR
RNA was purified using QIAGEN Quick Prep-Mini kit or cell
sorting directly into the pre-amplificaiton reaction mix. Samples
were then reverse transcribed and pre-amplified with 5 ul
CellsDirect 26Reaction Mix, 10 ul Superscript III TR/Platinum
Taq Mix (Invitrogen, CellsDirect One-Step qRT-PCR kit), 2.5 ul
of 0.56pooled primers and probes, 1.5 ul TE Buffer (QIAGEN)
and 0.1 ul SUPERaseIn (Applied Biosystems). Rt-PCR was
performed in 20 ul volumes with 10 ul ABI 26 Reaction Mix
(Applied Biosystems), 1 ul FAM probe, 1 ul VIC probe, 0.5–2 ul
of pre-amplified sample, fill remaining volume with water. Pre-
amp thermocycle: 95uC95C for 10 min, 18 cycles of 95C for
15 seconds, 60C for 4 min, and then hold at 4uC.4C. Expression
was normalized to the geometric mean of four housekeeping
genes: GAPDH, CTNNB1, EEF1A1, CENTB3 (Centrin). Genes
were then grouped into catagories representing developmental
stages and cell types, with a fold change induction, normalized to
the undifferentiated state, computed over the sample time points.
Immunofluorescence and alkaline phosphatase staining
Alkaline phosphatase (AP) staining was performed with VectorH
Red Alkaline Phosphatase Substrate Kit I (Vector Laboratories,
CA), according to the manufacturer’s protocol. For immunocyto-
chemistry, cells were fixed in 4% paraformaldehyde/PBS for
10 minutes, washed twice with PBS, and blocked with 1–3%
donkey, goat or chicken serum in PBS for 1 hour—all procedures
Figure 4. Analysis of oxidative stress levels and response to peroxide induced cell stress. (A–E) ANOVA significance analysis across Ctrl2,
Trpl17 and H9 cultures revealed five differentially expressed stress related genes. Trpl17 neural cultures had the highest expression of each ANOVA
identified differentially expressed stress related gene; DNAJA1, HMOX2, UCHL1, HSPB1 and MAO-A. (F) Confocal micrographs showing activated
Caspase-3 in Trpl17 DA cultures with and without H2O2 treatment. (G) A plot of the fraction of TH+ cells that were activated Caspase-3 positive for
each line with and without 200 mM H2O2 treatment. Error bars=S.E.M. and scale bars=100 mm (j) and 10 mm (k). *p,0.05, **p,0.001.
doi:10.1371/journal.pone.0026159.g004
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staining, after fixation, the cells were permeabilized with 0.3%
Triton-X100 for 30 minutes at room temperature. Subsequently,
the primary antibodies were added to PBS and incubated for
1 hour at room temperature or overnight at 4uC. The cells were
then washed with PBS before fluorescent-conjugated secondary
antibodies were added and incubated for an hour at room
temperature. Finally, the cells were rinsed with PBS three times
and counterstained with DAPI. Stained samples were imaged
directly on a LEICA inverted microscope or, if the samples were
on coverslips, were mounted in PVA-DAVCO overnight and then
imaged on an inverted Zeiss Confocal. Primary antibodies and
their dilutions were as follows: Oct4 (diluted at 1:100, Santa Cruz),
Sox2 (1:200, Millipore), SSEA1 (1:200, Millipore), SSEA4 (1:200,
Millipore), TRA1-60 (1:200, Millipore), TRA1-81 (1:200, Milli-
pore), Nanog (1:100, Abcam), a-Fetoprotein (1:200, Abcam), bIII-
Tubulin (1:200, Abcam), a-Smooth muscle actin (1:200, Abcam),
Vasa (1:200, Abcam) Nestin (1:200, Santa Cruz), Doublecortin
(1:200, Santa Cruz), Tyrosine hydroxylase (1:500, Pel-Freez
Biologicals), SNCA (1:500 or 1:1600, NeoMarkers), SNCA
(1:200, Thermo Scientific), SNCA (1:200, Labvision), Ubiquitin
(1:250, Millipore), FoxA2 (1:50, Santa Cruz). Secondary antibod-
ies were raised in either donkey, goat or rabbit with conjugates:
Alexa 488-conjugated anti-rabbit IgG (1:500, Invitrogen), Alexa
594-conjugated anti-rabbit (1:500, Invitrogen), Alexa 647-conju-
gated anti-rabbit (1:500, Invitrogen), Alexa 488-conjugated anti-
mouse IgM (1:500, Invitrogen) and Alexa 488 anti-mouse IgG
(1:500, Invitrogen), FITC anti-Mouse conjugated, Cy3 anti-
Rabbit, and Cy5 anti-Goat (1:500 Jackson Immuno). In
micrographs DAPI, FITC, Cy3, Cy5, are visualized as Blue,
Green, Red, and Yellow (or Blue, when DAPI is removed).
Bisulfite sequencing
To determine methylation regions, bisulfite sequencing was
performed on genomic DNA isolated from hESCs and iPSCs,
grown on feeder-free media, with Methyl Easy Xceed Rapid DNA
Bisulfite Modification Kit (Human Genetic Signatures, Sydney,
New South Wales, Australia) per manufacturers directions. The
promoter regions of Oct3/4 and Nanog were amplified by PCR,
as previously described [33]. PCR products were subcloned into
pCR2.1 TOPO (Invitrogen), and twelve clones from each sample
were analyzed by sequencing with M13 universal primer.
Spectral karyotyping
To prepare metaphase spreads, 10 ml/mL colcemid was added
to the cell culture and incubated for up to 2 hours. The growth
medium was removed and collected and the cells were rinsed with
HBSS. Cells were treated with 2 mL trypsin and incubated at
37uC for 5–7 min. The collected colcemid medium from the
earlier step was re-applied to the cells to stop neutralize the trypsin
and resuspend the cells. Resulting solution was centrifuged at 1000
RPM for 6 min and the supernatant was partially aspirated and
resuspended in the native solution by flicking the tube. 5 drops of
pre-warmed hypotonic solution were slowly added against the side,
while flicking with a finger, until 1 ml had been added. Volume
was then brought to 2 mL with hypotonic solution. The sample
was incubated at 37uC for 7 min and then centrifuged at 1000
RPM for 6 min. Medium was added to resuspend the cells. To fix
the cells, 5 drops of fixative were slowly added against the side of
the tube and the volume was brought to 2 mL with fixative. Cells
were gently mixed and fixed for 30 min at room temperature.
After fixing, the sample was centrifuged, aspirated, and resus-
pended as above. Any clumps were removed by vacuum from the
side of tube, and 2 ml of fixative were added to the tube. Sample
was then mixed, incubated for 20 min at room temperature,
centrifuged, aspirated, and resuspended in 2 ml of fixative.
Samples were transferred onto pre-cleaned slides in ,100 ul
drops, left to dry overnight, and then analyzed on a SKY
microscope (Spectral-Imaging, Vista, CA).
SNCA Triplication Confirmation
SNCA gene copy number analysis: Genomic DNA was isolated
from frozen cell pellets using a DNeasy Blood & Tissue Kit
(Qiagen 69504). A FAM-MGB Taqman Copy Number Assay
against the 3
rd intron of SNCA (Hs04791950_cn) and a VIC-
TAMRA Taqman Copy Reference Assay against RNase P
(#4403326) were used with Taqman Genotyping MasterMix
(#4371353; Applied Biosystems) to co-amplify 20 ng of genomic
DNA in quintuplicate from each sample on a Stratagene
Mx3000P RT-PCR System. The absolute copy number of SNCA
for each sample is reported by calculating the relative copy
number (SNCA/RNase P) for each reaction (2
2DCT) and then
adjusting by a factor of 2 which reflects the normal allelic copy
number of RNase P in the genome. 2 alleles of SNCA are
normally present, a duplication of SNCA yields 3 alleles, and a
triplication of SNCA yields 4 alleles.
Exogenous and Endogenous Expression Analysis
Primer sequences used for determining exogenous and endog-
enous expression of the OCT4, SOX2, KLF4 and c-MYC.
Exogenous: pMXs-AS3200: ttatcgtcgaccactgtgctgctg (Used as
Reverse primer for all) OCT4- Forward: ccccagggccccattttggtacc.
SOX2- Forward: ggcacccctggcatggctcttggctc. KLF4- Forward: a-
cgatcgtggccccggaaaaggacc. cMYC-Forward: caacaaccgaaaatgcac-
cagccccag. Endogenous: OCT4-Reverse: cctagctcctcccctccccctgtc.
(Use the above primers as Forward) SOX2-Reverse: cctcttttgca-
cccctcccatttccc. KLF4-Reverse: tgattgtagtgctttctggctgggctcc. cMY-
C-Foward: ttgaggggcatcgtcgcgggaggctg. cMYC-Reverse: cgagag-
gaccccgtggatgcagag.
In-vitro differentiation
To investigate in vitro differentiation, cell culture medium was
replaced with ,80% KO DMEM, 20% fetal bovine serum (FBS),
1% 1006L-glutamine, 1% 1006BME, 1% 1006non-essential
amino acids (NEAA), and 1% 1006penicillin-streptomycin. After
culturing for the desired time period, cells were either stained for
Immunocytochemistry or harvested for protein or RNA analysis.
In-vivo teratoma formation and immunohistochemistry
As sated previously, animal work was approved under Stanford
guidelines for animal safety and received approval from Stanford’s
administrative panel on laboratory animal care (approval APLAC-
16146) and SCRO (approval SCRO-212). To determine iPSC
potential to form all three germ layers in vivo, hESCs and iPSCs
cells were harvested from 6-well or 10 cm plates through brief
Collagenase IV treatment and transferred to 200 ul of hESC
medium. The cells were either grafted subcutaneously behind the
neck or in the hind limp muscles of female SCID mice (Charles
River). After 8–10 weeks post-transplantation, grafts were
dissected and fixed with 4% paraformaldehyde/PBS overnight.
The tissues were then paraffin embedded, sectioned and stained
with Masson’s Trichrome, Mayer’s Mucicarmine, Saffron O and
Hematoxylin and Eosin.
Directed midbrain dopaminergic differentiation
To direct differentiation of pluripotent cell colonies towards a
midbrain dopaminergic (DA) neuron cell fate, a modified
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25.
Two or three hESC or iPSC colonies were mechanically
harvested and gently dissected into 4–6 pieces per colony. Cells
were then plated onto a 6 cm co-culture dish with irradiated
MS-5 (xMS-5) stromal cells (MS-5 cells were expanded in MS-5
s t r o m a lc e l lc u l t u r em e d i u m :4 5 5 m la - M E M ,2 m ML -
glutamine, 50 ml heat inactivated FBS, Pen-strep) and cultured
for 16 days in Serum Replacement Media (15% KOSR in KO-
DMEM, GIBCO), with media changes every two days. After 16
days, media was changed to N2+/+ (progesterone 20 nM,
putrescine 100 uM, sodium selenite 30 nM, insulin 5 ug/ml,
t r a n s f e r r i n0 . 1 m g / m li nD M E M - F 1 2 ,G I B C O ) .A td a y2 8 ,
neural rosettes in the colonies were passaged through mechan-
ical micro-dissection and transferred onto Poly/Laminin coated
(15 ug/ml polyornithine, 1 ug/ml laminin, SIGMA) 6-well
plates and cultured for one week in 200 ng/ml Sonic Hedgehog
(SHH-C24II (a more active form than the unmodified protein),
R&D Systems), 100 ng/ml Fibroblast Growth Factor 8 (FGF-8,
R&D Systems), 20 ng/ml Brain Derived Neurotrophic Factor
(BDNF, R&D Systems), and 0.2 mM Ascorbic Acid (AA,
SIGMA) in N2+/+ media. On day 35, when cultures were
approximately 80% confluent, colonies were passaged through
digestion in Ca
2+/Mg
2+ free HBSS (GIBCO) at room temper-
ature for 1 hour and subsequent mechanical dissociation.
Removed cell aggregates were centrifuged at 200 g for
5 minutes, resuspended and plated on Poly/Laminin coated
dishes at 50–100610
3 cells/cm
2 in N2+/+ media with the
previously noted, day 28, growth factors. On day 42,
differentiation was induced for 8 days through growth factor
withdrawal by changing media to N2+/+ with 20 ng/ml BDNF,
20 ng/ml Glial Derived Neurotrophic Factor (GDNF, R&D
Systems), 1 ng/ml TransformingG r o w t hF a c t o rB 3( T G F - B 3 ,
R&D Systems), 1 mM dibutyryl Cyclic Adenosine MonoPhos-
phate (cAMP, SIGMA) and 0.2 mM AA in N2+/+ media. On
day 50, cell cultures were harvested for analysis.
HPLC Dopamine Release:
After 60 days of iPSC patterning and differentiation into
dopamine neurons, neurons were depolarized to evoke dopa-
mine release. Media was removed and 1 ml of N2 media
supplemented with 56 mM KCl was added per well (6 well dish)
a n di n c u b a t e da t3 7 uCf o r1 5 m i n u t e s .T h em e d i u mw a s
collected and immediately frozen in liquid nitrogen and stored
at 280uC until assay. Protein lysates were used to estimate
relative cell number in each well. Lysates were made in ice cold
25 mM Tris supplemented with a Complete Mini protease
inhibitor cocktail tablet (Roche). Lysates were sonicated and
cleared by maximum speed centrifugation in a tabletop
microcentrifuge. Soluble protein concentrations were measured
by a standard Bradford assay. To measure dopamine, media
samples were thawed, stabilized at a final concentration of 0.4 N
perchloric acid, and centrifuged at 15,000 rpm at 4uCf o r
12 minutes to clear debries. The supernatant was then collected
and dopamine was assayed by HPLC with electrochemical
detection (Coularray detector, ESA, Chelmsford, MA) using a
reverse phase C18 column (Perkin Elmer Instruments, Shelton,
CT). The mobile phase consisted of a mixture of 90 mM sodium
acetate, 35 mM citric acid, 130 uM ethylenediaminetetraaceti-
cacid (EDTA), 230 uM 1-octanesulfonic acid and 10% (v/v)
methanol, with a flow rate of 1 mL/min. DA concentration was
quantified by comparison of AUC to known standard dilutions.
Dopamine release was normalized to protein determinations of
cleared protein lysates.
Electrophysiology
IPSC-derived cells cultured on glass coverslips were accessed via
whole-cell patch clamp and assayed for their ability to generate
action potentials in current clamp (CC). Electrophysiological
recordings were obtained in Tyrode media ([mM] 150 NaCl,
4 KCl, 2 MgCl2, 2 MgCl2, 10 D-glucose, 10 HEPES, pH 7.35
with NaOH) using a standard internal solution ([mM] 130
KGluconate, 10 KCl, 10 HEPES, 10 EGTA, 2 MgCl2, pH 7.3
with KOH) in 3–5 MV glass pulled pipettes. Square pulse current
steps of varying sizes and frequencies were injected to patched cells
held at resting potential. Cells were chosen for patching based on
either 1) their proximity or apparent extension of neuronal
processes or 2) morphological similarity to typical neurons.
a-Synuclein Western Blotting
Western blotting was performed to determine a-synuclein in
iPSC-derived DA neuron cultures possessing an SNCA triplica-
tion. 20 ug of protein lysates harvested from Trpl17, Ctrl2 and H9
cell derived neuron cultures (60 DIV, 2 independent wells per
sample) were subjected to SDS-PAGE and stained for a-synuclein
(Thermo Scientific), stripped and re-stained for GAPDH (SIG-
MA). Monomeric a-synuclein was observed at approximately
17 kDa. Band intensities were measured using Image J, and ratio
of monomeric a-synuclein/GAPDH was calculated for each
sample. Results were reported as the means of two samples with
error bars representing SEM. A one-way ANOVA with Duncan’s
post-hoc analysis found that Trpl17 neuronal cultures (possessing 4
genomic copies of SNCA) expressed roughly twice as much
monomeric a-synuclein as Ctrl2 and H9 neuronal cultures
(possessing the normal 2 genomic copies of SNCA).
Statistical analysis
Student’s t-test was used for comparing two samples with
adequate sample numbers. For determining statistical significance
between more than two groups, a one-way ANOVA was used with
either Duncan’s or Bonferroni’s post-hoc analysis. Data was
analyzed either in InStat Version 3.0a, Microsoft Excel v12.20 or
MATLAB 2008.
Supporting Information
Figure S1 Characteristics of iPSC lines. (A) Expression of
pluripotency related markers alkaline phosphatase (AP), TRA-160,
SSEA3, Nanog, TRA-181, SSEA4 and the absence of SSEA1 are
shown for SNCA triplication iPSC clones Trpl8 and Trpl43.
Stability of reprogrammed lines was assessed through (B) Spectral
SKY karyotype analysis of iPSC lines. Shown here are
representative karyotypes of Trpl17 and Ctrl2 iPSC line
metaphase spreads. 20 replicates for each line showed no
translocations, triplications, or deletions. (Replicates not shown).
(C) Relative copy count from quantitative PCR analysis of
endogenous and exogenous OCT3/4, SOX2, Klf4, and cMYC
transcription factor expression in untransduced fibroblasts (Trpl-
HDF and Ctrl-HDF), different pluripotent iPSC lines derived from
Trpl-HDF (Trpl17 and Nrml46) and Ctrl-HDF (Ctrl2 and Ctrl3),
pluripotent hESC line H9, and control HeLa RNA.
(PDF)
Figure S2 Epigenetic status of pluripotency and im-
printed genes. (A) Methylation status of NANOG and OCT4
promoters as determined by bisulfide sequencing in untransduced
fibroblasts (Trpl-HDF and Nrml-HDF) and pluripotent iPSC lines
(Trpl17 and Nrml2). (B) Differential methylated regions on
paternal, KCNQ1OT1, and maternal, H19, imprinting sites
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lyation, suggesting the maintenance of a stable epigenetic state
through reprogramming.
(TIF)
Figure S3 Pluripotency related telomerase activity.
Relative telomerase activity in: untransduced HDF lines (Trpl2-
HDF and Ctrl2-HDF); pluripotent iPSC lines Trpl17, Trpl46,
Ctrl2 and Nrml3; hESC line HSF8; differentiated iPSC lines 4c17
and Ctrl2; negative buffer only control; and a TSR8 positive
control. Heat inactivation used as an internal control. *p,0.01.
(TIF)
Figure S4 Differentiation of iPSC lines. (A) Confocal
micrographs of a-Fetoprotein protein is detected by antibody
recognition in EB spontaneous differentiation in iPSC lines Trpl17
and Ctrl2, indicative of endoderm lineage. Scale bars=100 mm.
(B) Further characterization of iPSC pluripotency. iPSC lines
Trpl17 and Ctrl2 are capable of forming embryoid bodies in ultra-
low adhesion plates and, when allowed to adhere, these embryoid
bodies are able to spontaneously form beating cardiomyocytes.
Scale bars=200 mm.
(TIF)
Figure S5 Schematic of DA neuron differentiation from
pluripotent stem cells. Protocol requires 50 days of differen-
tiation and two passaging steps. Working concentrations for
growth factors are: Sonic Hedgehog (SHH)-(Cys-24 modi-
fied)=200 ng/ml, FGF8=100 ng/ml, Brain-Derived Neur-
trophic Factor (BDNF)=20 ng/ml, Glial Derived Neurtrophic
Factor (GDNF)=10–20 ng/ml, Transforming Growth Factor-B3
(TGF b3)=1 ng/ml, Dibutyl Cyclic Adenosine Monophosphate
(Dibutyl cAMP)=0.5–1.0 mM, Ascorbic Acid=0.2 mM.
(TIF)
Figure S6 Neuronal differentiation. (A) Day 50 DA neuron
differentiation culture phase contrast micrographsofTrpl17, Nrml2
and H9. (B) Day 50 DA neuron differentiation IF confocal 206
micrograph showing a 423 mmT H + axon extending from a DA
neuron. (C) Trpl17 derived neurons express PAX6 in culture with
TH and Nestin. Scale bars represent 200 mm (a) and 100 mm (b,c).
(TIF)
Figure S7 Full heatmap display of Fluidigm qPCR
results. Gene list is filtered for those with $30% samples
containing valid CT counts. Genes and samples were complete
linkage clustered with uncentered correlation similarity metric
using Cluster. Results were visualized in TreeView. The set was
analyzed for correllation groups with known biochemical similar-
ities. Gene categories labeled are discussed in Fig. 3.
(TIF)
Figure S8 Transcript analysis of midbrain dopaminer-
gic neuron differentiation over 50 days for pluripotent
lines Trpl17, Ctrl2 and H9. Pluripotency markers Oct4, c-
Myc and TERT are turn off at the neural stem cell stage (NSC)
and remain silenced in DA neurons. Notably, DNMT3B (a
denovo DNA methyltransferase) shows moderate silencing at the
NSC stage, while expression returns upon further differentiation to
DA neurons. Neural associated markers NCAM, TH, MAOA,
MAOB and SNCA show higher expression as the differentiation
proceeds towards DA neurons. The relative ratio of Robo2,
Robo1 and DDC (axon guidance associated proteins) is shown as a
fraction of their total expression between the three stages of
differentiation - Trpl17 derived neurons appear to express a higher
fraction of Robo1 against Robo2 and DDC than the control lines.
(TIF)
Figure S9 IF confocal micrographs for Trpl17 derived
neurons. Colocalization of SNCA and TH immunoreacivity,
suggesting that DA neurons can express alpha-synuclein.
(TIF)
Figure S10 (A) IF shows immunoreactivity colocaliza-
tion of Ubiquitin and TH when Ubiquitin was expressed
at a low level. However, cells demonstrating strong Ubiquitin
accumulation immunoreactivity were not positive for TH. (B)
Confocal micrographs showing activated Caspase-3 in Trpl17 DA
cultures with and without H2O2 treatment. Scale bars=10 mm
(a,b) and 100 mm (d). Error bars=s.e.m.
(TIF)
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